COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT04465695

Ivan FN Hung, MD FRCP

ivanhung@hku.hk

2020-07-10

Unknown

RCT

Randomized

Parallel

Open label

single-center

Treatment

inclusion criteria: recruited subjects include all adult patients 18 years or above hospitalized for virologic confirmed sars-cov-2 infection. all subjects give written informed consent. for patients who are critically ill, requiring icu, ventilation or confused, informed consent will be obtained from spouse, next-of-kin or legal guardians. subjects must be available to complete the study and comply with study procedures. willingness to allow for serum samples to be stored beyond the study period, for potential additional future testing to better characterize immune response

inability to comprehend and to follow all required study procedures. allergy or severe reactions to the study drugs patients taking medication that will potentially interact with l interferon beta-1b or clofazimine patients with known history of severe depression received an experimental agent (vaccine, drug, biologic, device, blood product, or medication) within 1 month prior to recruitment in this study or expect to receive an experimental agent during this study. to participate in an unrelated trial during the current clinical trial. nevertheless, the patients have the right to withdraw from the current clinical trial to join another clinical trial. have a history of alcohol or drug abuse in the last 5 years. have any condition that the investigator believes may interfere with successful completion of the study

3

The University of Hong Kong

18

100

China

No restriction on type of patients

0: No restriction on type of patients

81

Clinical alleviation of symptoms

None

Phase 2

[{"arm_notes": "", "treatment_id": 2211, "treatment_name": "Clofazimine+interferon beta 1b", "treatment_type": "Antibiotics+interferons", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 298, "treatment_name": "Clofazimine", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]